LBRX LB Pharmaceuticals Inc Common Stock
Healthcare$28.12+0.43%ClosedMarket Cap: $806.4M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
2.10
P/S
0.00
EV/EBITDA
-10.59
DCF Value
$9.67
FCF Yield
-6.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-17.7%
ROA
-10.0%
ROIC
-12.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-22.1M | $-19.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-13.9M | $-11.5M | $— | — |
| FY null | $0.00 | NaN% | $-30.4M | $-25.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-5.2M | $-3.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-5.6M | $-5.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-5.6M | $-5.1M | $— | — |
| FY null | $0.00 | NaN% | $-64.8M | $-63.1M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-16.1M | $-14.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-26.6M | $-27.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-16.6M | $-16.2M | $— | — |
| FY null | $0.00 | NaN% | $-11.4M | $-6.3M | $— | — |
| FY null | $0.00 | NaN% | $-2.8M | $-14.3M | $— | — |